Nestlé Skin Health is part of Nestlé's global business portfolio. To meet a broad range of skin health needs, we offer a range of leading medical and consumer skin health brands, through three business units: Prescription, Aesthetics (both under the Galderma brand), and Consumer care.
Key facts
- Sales by business
- Consumer 41%
- Aesthetics 35%
- Prescription 24%
- Sales by region
- North America 50.4%
- International 49.6%
- In 2018, the 1,200+ employees at our 6 manufacturing sites produced 215 million units. We make 75% of our products in house.
CSR Policy Financial Year 2017-2018
CSR Policy Financial Year 2018-2019
A timeline of our history
1981
Foundation of Galderma
1984
Galderma discovers Adapalene
1986
First commercial operations
1995
Acne treatment Differin launch
2000
Opening of production site in Baie d’Urfé, Canada
2001
Licensing agreement for Metvix (Skin cancer)
2004
Opening of production site in Hortolândia, Brazil
2007
Launch of Differin 0.3%
2008
Launch of Epiduo
2009
Launch of Azzalure and Restylane Injector